Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints
Online Access
http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Strategies+and+practices+in+off-label+marketing+of+pharmaceuticals:+a+retrospective+analysis+of+whistleblower+complaints.&title=PLoS+medicine+&volume=8&issue=4&date=2011-04&au=Kesselheim,+Aaron+S;+Mello,+Michelle+M;+Studdert,+David+Mhttps://dx.doi.org/10.1371/journal.pmed.1000431
http://hdl.handle.net/10822/1017680
Abstract
Despite regulatory restrictions, off-label marketing of pharmaceutical products has been common in the US. However, the scope of off-label marketing remains poorly characterized. We developed a typology for the strategies and practices that constitute off-label marketing.Date
2016-01-09Identifier
oai:repository.library.georgetown.edu:10822/1017680doi:10.1371/journal.pmed.1000431
PLoS medicine 2011 Apr; 8(4): e1000431
http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Strategies+and+practices+in+off-label+marketing+of+pharmaceuticals:+a+retrospective+analysis+of+whistleblower+complaints.&title=PLoS+medicine+&volume=8&issue=4&date=2011-04&au=Kesselheim,+Aaron+S;+Mello,+Michelle+M;+Studdert,+David+M
http://dx.doi.org/10.1371/journal.pmed.1000431
http://hdl.handle.net/10822/1017680
DOI
10.1371/journal.pmed.1000431ae974a485f413a2113503eed53cd6c53
10.1371/journal.pmed.1000431